EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate (Glivec)

M. W. Bekkenk; M. H. Vermeer; C. J.L.M. Meijer; P. M. Jansen; J. M. Middeldorp; S. J.C. Stevens; R. Willemze

doi:https://doi.org/10.1007/3-7985-1610-3_29

EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate (Glivec)

M. W. Bekkenk, M. H. Vermeer, C. J.L.M. Meijer, P. M. Jansen, J. M. Middeldorp, S. J.C. Stevens, R. Willemze

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

Original language	English
Title of host publication	Cutaneous Lymphomas Unusual Cases 2
Publisher	D. Steinkopff-Verlag
Pages	62-63
Number of pages	2
ISBN (Print)	379851609X, 9783798516090
DOIs	https://doi.org/10.1007/3-7985-1610-3_29
Publication status	Published - 2006

Access to Document

https://doi.org/10.1007/3-7985-1610-3_29

Cite this

@inbook{c00e6f43499848a2a7710e8b4f40b8b3,

title = "EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate (Glivec)",

author = "Bekkenk, {M. W.} and Vermeer, {M. H.} and Meijer, {C. J.L.M.} and Jansen, {P. M.} and Middeldorp, {J. M.} and Stevens, {S. J.C.} and R. Willemze",

year = "2006",

doi = "https://doi.org/10.1007/3-7985-1610-3_29",

language = "English",

isbn = "379851609X",

pages = "62--63",

booktitle = "Cutaneous Lymphomas Unusual Cases 2",

publisher = "D. Steinkopff-Verlag",

address = "Germany",

}

TY - CHAP

T1 - EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate (Glivec)

AU - Bekkenk, M. W.

AU - Vermeer, M. H.

AU - Meijer, C. J.L.M.

AU - Jansen, P. M.

AU - Middeldorp, J. M.

AU - Stevens, S. J.C.

AU - Willemze, R.

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=84895253165&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/3-7985-1610-3_29

DO - https://doi.org/10.1007/3-7985-1610-3_29

M3 - Chapter

SN - 379851609X

SN - 9783798516090

SP - 62

EP - 63

BT - Cutaneous Lymphomas Unusual Cases 2

PB - D. Steinkopff-Verlag

ER -

EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate (Glivec)

Access to Document

Other files and links

Cite this